Herbal Products and Other Supplements: Use by Elderly Veterans with Depression and Dementia and Their Caregivers

Journal of Geriatric Psychiatry and Neurology

Volumn 17, Issue 1, 2004, Pages 25-31

  Kales, Helen C ^a,b   Blow, Frederic C ^a,b   Welsh, Deborah E ^a   Mellow, Alan M ^b  

^a VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Alternative medicine; Dementia; Depression; Elderly

Indexed keywords

ACETYLSALICYLIC ACID; ARCTOSTAPHYLOS UVA URSI EXTRACT; ARNICA MONTANA EXTRACT; CHONDROITIN; COD LIVER OIL; CODEINE; DIGOXIN; ECHINACEA EXTRACT; GINGER EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; GLUCOSAMINE; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; IBUPROFEN; LAMOTRIGINE; MELATONIN; MIRTAZAPINE; NATURAL PRODUCT; NEFAZODONE; OXAZEPAM; PAROXETINE; PHENYTOIN; PRIMROSE OIL; SABAL EXTRACT; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRAZODONE; UNINDEXED DRUG; XANTHOPHYLL;

AGED; ARTICLE; CAREGIVER; DEMENTIA; DEPRESSION; EDUCATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; PHYSICIAN; PRIORITY JOURNAL; SOLDIER; SYMPTOMATOLOGY; UNITED STATES;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; CAREGIVERS; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; DIETARY SUPPLEMENTS; DRUG UTILIZATION; DRUGS, CHINESE HERBAL; EDUCATIONAL STATUS; HERB-DRUG INTERACTIONS; HOSPITALS, VETERANS; HUMANS; MALE; MENTAL STATUS SCHEDULE; MICHIGAN; PATIENT EDUCATION; PHYTOTHERAPY; VETERANS;

EID: 1542320577     PISSN: 08919887     EISSN: None     Source Type: Journal    
DOI: 10.1177/0891988703261998     Document Type: Article

References (26)

1. Eisenberg DM, Davis RB, Ettner SL, et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 1998; 280:1569-1575.
2. Kaufman DW, Kelly JP, Rosenberg L, et al. Recent patterns of medication use in the ambulatory adult population of the United States: the Sloane survey. JAMA 2002; 287:337-344.
3. Astin JA. Why patient use alternative medicine: results of a national study. JAMA 1998; 279:1548-1553.
4. Busto UE, Sproule BA, Knight K, et al. Use of prescription and nonprescription hypnotics in a Canadian elderly population. Can J Clin Pharmacol 2001; 8:213-221.
5. Foster DF, Phillips RS, Hamel MB, et al. Alternative medicine use in older Americans. J Am Geriatr Soc 2000; 48:1560-1565.
6. Astin JA, Pelletier KR, Marie A, et al. Complementary and alternative medicine use among elderly persons: one-year analysis of a Blue-Shield Medicare supplement. J Gerontol A Biol Sci Med Sci 2000; 55:M4-9.
7. Coleman LM, Fowler LL, Williams ME. Use of unproven therapies by people with Alzheimer's disease. J Am Geriatr Soc 1995; 43:747-750.
8. Hogan DB, Elby EM. Complementary medicine use in a dementia clinic population. Alzheimer Dis Assoc Disord 1996; 10:63-67.
9. Rosenblatt M, Mindel J. Spontaneous hyphema associated with ingestion of ginkgo biloba extract. N Engl J Med 1997; 336:1108.
10. Matthews MK. Association of ginkgo biloba with intracerebral haemorrhage. Neurology 1998; 5:19-33.
11. Galluzi S, Zanetti O, Binetti G, et al. Coma in a patient with Alzheimer's disease taking low dose trazodone and ginkgo biloba. J Neurol Neurosurg Psychiatry 2000; 68:679-683.
12. Gordon JB. SSRIs and St. John's wort: possible toxicity? Am Fam Phys 1998; 57:950.
13. Yue Q-Y, Bergquist C, Gerden B. Safety of St. John's wort (Hypericum perforatum). Lancet 2000; 355:576-577.
14. Ruschitzka F, Meier PJ, Turina M, et al. Acute heart transplant rejection due to St. John's wort. Lancet 2000; 355:548-549.
15. Johne A, Brockmoller J, Bauer S, et al. Pharmacokinetic interaction of digoxin with an herbal extract from St. John's wort (Hypericum perforatum). Clin Pharmacol Ther 1999; 66:338-345.
16. Jones BD, Runikis AM. Interaction of ginseng with phenylzine. J Clin Psychopharmacol 1987; 7:201-202.
17. Janetzky K, Morreale AP. Probable interactions between warfarin and ginseng. Am J Health Syst Pharm 1997; 54:692-693.
18. Kales HC, Valenstein M. Complexity in late-life depression: impact of confounding factors on diagnosis, treatment and outcomes. J Geriatr Psychiatry Neurol 2002; 15:147-155.
19. Agha Z, Lofgren RP, VanRuiswyk JV, et al. Are patients at veterans affairs medical centers sicker? A comparative analysis of health status and medical resource use. Arch Intern Med 2000; 160:3252-3257.
20. Sheikh JI, Yesavage JA. Geriatric depression scale (GDS): recent evidence and development of a shorter version. Clin Gerontol 1986; 6:165-173.
21. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
22. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
23. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993; 43:250-260.
24. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.
25. Linn BS, Linn MW, Gurel L. Cumulative illness rating scale. J Am Geriatr Soc 1968; 16:622-626.
26. Izzo AA, Ernst E. Interactions between herbal medicines and prescribed drugs. Drugs 2001; 61:2163-2175.